Healthcare provider profile · identity verified

Xavier D Kee, MD

Family Practice · ROCKVILLE, MD · NPI 1437446960

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1270	432
Amlodipine Besylate	Amlodipine Besylate	747	251
Lisinopril	Lisinopril	451	151
Losartan Potassium	Losartan Potassium	407	132
Metformin Hcl Er	Metformin Hcl	380	139
Hydrochlorothiazide	Hydrochlorothiazide	283	99
Arexvy	Rsvpref3 Antigen/As01e/Pf	282	282
Metformin Hcl	Metformin Hcl	232	86
Glipizide	Glipizide	221	75
Atenolol	Atenolol	194	67
Furosemide	Furosemide	182	69
Metoprolol Tartrate	Metoprolol Tartrate	167	60
Famotidine	Famotidine	158	59
Tamsulosin Hcl	Tamsulosin Hcl	147	64
Levothyroxine Sodium	Levothyroxine Sodium	140	44
Allopurinol	Allopurinol	137	46
Albuterol Sulfate Hfa	Albuterol Sulfate	135	62
Gabapentin	Gabapentin	131	58
Rosuvastatin Calcium	Rosuvastatin Calcium	126	39
Hydralazine Hcl	Hydralazine Hcl	123	47
Pradaxa	Dabigatran Etexilate Mesylate	118	41
Jardiance	Empagliflozin	114	42
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	114	36
Carvedilol	Carvedilol	111	45
Metoprolol Succinate	Metoprolol Succinate	107	37
Pantoprazole Sodium	Pantoprazole Sodium	105	42
Tramadol Hcl	Tramadol Hcl	98	28
Meloxicam	Meloxicam	92	60
Spiriva Respimat	Tiotropium Bromide	86	23
Duloxetine Hcl	Duloxetine Hcl	77	33
Prednisone	Prednisone	74	65
Potassium Chloride	Potassium Chloride	73	26
Wixela Inhub	Fluticasone Propion/Salmeterol	70	23
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	67	21
Clopidogrel	Clopidogrel Bisulfate	65	23
Trazodone Hcl	Trazodone Hcl	65	28
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	56	suppressed
Simvastatin	Simvastatin	54	19
Shingrix	Varicella-Zoster Ge/As01b/Pf	52	49
Finasteride	Finasteride	49	16
Pregabalin	Pregabalin	46	suppressed
Clonidine Hcl	Clonidine Hcl	45	16
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	45	16
Montelukast Sodium	Montelukast Sodium	44	19
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	43	15
Terazosin Hcl	Terazosin Hcl	43	16
Insulin Syringe	Syring-Needl,disp,insul,0.3 Ml	41	12
Humulin N	Insulin Nph Human Isophane	40	15
Warfarin Sodium	Warfarin Sodium	39	13
Alvesco	Ciclesonide	38	17
Alendronate Sodium	Alendronate Sodium	34	11
Insulin Syringe	Syringe And Needle,insulin,1ml	33	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	33	11
Lactulose	Lactulose	33	19
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	33	15
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	31	31
Chlorthalidone	Chlorthalidone	31	11
Ibuprofen	Ibuprofen	31	22
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	31	suppressed
Nystatin	Nystatin	30	14
Pravastatin Sodium	Pravastatin Sodium	30	suppressed
Spironolactone	Spironolactone	30	suppressed
Azelastine Hcl	Azelastine Hcl	29	17
Lovastatin	Lovastatin	29	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	29	16
Verapamil Er	Verapamil Hcl	28	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	27	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	26	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	26	suppressed
Colchicine	Colchicine	25	17
Citalopram Hbr	Citalopram Hydrobromide	20	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	20	20
Eliquis	Apixaban	19	suppressed
Humulin R	Insulin Regular, Human	19	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	18	18
Donepezil Hcl	Donepezil Hcl	18	suppressed
Fluocinonide	Fluocinonide	18	13
Fluticasone Propionate	Fluticasone Propionate	18	suppressed
Omeprazole	Omeprazole	17	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	17	17
Clonidine	Clonidine	16	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	15
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	14	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	14	suppressed
Labetalol Hcl	Labetalol Hcl	14	suppressed
Mirtazapine	Mirtazapine	14	suppressed
Xarelto	Rivaroxaban	14	suppressed
Humalog	Insulin Lispro	13	suppressed
Torsemide	Torsemide	13	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	12	12
Entresto	Sacubitril/Valsartan	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Valsartan	Valsartan	12	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Sertraline Hcl	Sertraline Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error